Protein Arginine Methyltransferase 7 (PRMT7) Peptide
-
- Target See all PRMT7 products
- PRMT7 (Protein Arginine Methyltransferase 7 (PRMT7))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GEINDQDRTD HYAQALRTVL LPGSVCLCVS DGSLLSMLAH HLGAEQVFTV
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of Prmt7 antibody,
Alternative Names: Prmt7 control peptide, Prmt7 antibody Blocking Peptide, Anti-Prmt7 Blocking Peptide, protein arginine N-methyltransferase 7 Blocking Peptide, 4933402B05Rik Blocking Peptide, BC006705 Blocking Peptide, MGC7929 Blocking Peptide, Prmt7, Prmt-7, Prmt 7, Prmt-7 Blocking Peptide, Prmt 7 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- PRMT7 (Protein Arginine Methyltransferase 7 (PRMT7))
- Background
- Prmt7 is a arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA), with a preference for the formation of MMA. It specifically mediates the symmetrical dimethylation of arginine residues in the small nuclear ribonucleoproteins Sm D1 (SNRPD1) and Sm D3 (SNRPD3), such methylation being required for the assembly and biogenesis of snRNP core particles.
- Molecular Weight
- 78 kDa
-